Below, you'll find a list of our latest COVID-19 drug-related coverage.
FDA Approves Remdesivir for COVID-19
Accelerated Screen Identifies 25 Existing Drugs Capable of Disrupting SARS-CoV-2 Cell Entry
Could Amodiaquine Be Effective at Fighting COVID-19?
NIH Study Designed To Identify Promising COVID-19 Treatments for Larger Clinical Trials
ILC Therapeutics Announces COVID-19 Drug Development
Breaking COVID-19’s "Clutch" To Stop Its Spread
Team Identifies Small Molecules That Target SARS-CoV-2 RNA for Destruction
Could a Lipid Be Used To Prevent or Treat SARS-CoV-2 Infection?
REGN-COV2 Antibody Cocktail Reduced Viral Load and Alleviated Symptoms in Non-Hospitalized COVID-19 Patients
Phase 3 Trial Assesses Dual-Antibody Injection's Ability To Prevent SARS-CoV-2 Infection
Team Uncovers New Mechanism of Action Against SARS-CoV-2 by Remdesivir
Drug Shown To Modulate the Inflammatory Response in Severe COVID-19
Tiny Antibody Component Neutralizes SARS-CoV-2 in Animal Models
COVID-19 Phase 3 Trial To Evaluate REGN-COV2 Antibody Cocktail in UK
COVID-19 Drug Discovery and Development – Why Diverse Strategies Are Critical
Synthetic Antiviral Proteins Inhibit SARS-CoV-2 in Lab-Grown Human Cells
The Impact of Genetics on COVID-19 Treatments
Risk of Severe COVID-19 Was Reduced for Patients Taking Blood Pressure Drug
Treating COVID-19 – 21 Existing Drugs Shown To Stop Replication of SARS-CoV-2
Could Steroids Be Used To Combat COVID-19 in Severely Ill Patients?
Ebselen May Be Effective as a Weapon Against Key Coronavirus Enzyme
Machine Learning Approach Identifies Potential Drug Candidates To Treat COVID-19
Study Indicates a Lack of Diversity in COVID-19 Clinical Trials
Existing Alcoholism Drug Potentially Effective Against COVID-19
RLF-100 Trial Shows Rapid Recovery From Respiratory Failure in Critically Ill Patients With COVID-19
Trial Tests Cancer Drug’s Ability To Reduce Respiratory Symptoms of COVID-19
Phase 2 Trial Launched To Investigate LAM-002A as a Treatment for COVID-19
Seaweed Extract Surpasses Remdesivir at Blocking SARS-CoV-2 in Cell Models of COVID-19
Team Identifies 21 Existing Drugs That Stop Replication of SARS-CoV-2
Chloroquine Does Not Inhibit SARS-CoV-2 Infection of Human Lung Cells